The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
UroGen Pharma Ltd(NASDAQ:URGN) 
UroGen Pharma Ltd., a biopharmaceutical company, engages in the development and commercialization novel solutions for specialty cancers and urologic diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmy...
Website: http://www.urogen.com
Founded: 2004
Full Time Employees: 187
Sector: Healthcare
Industry: Biotechnology
UroGen Pharma Days Payable Outstanding ttm (DPO)
UroGen Pharma Days Receivable Outstanding ttm (DSO)
UroGen Pharma Days Inventory Outstanding ttm (DIO)
UroGen Pharma Op Cashflow Per Share ttm
UroGen Pharma Free Cashflow Per Share ttm
UroGen Pharma Cash Per Share ttm
UroGen Pharma P/S ratio ttm
UroGen Pharma (GAAP) P/E ratio ttm
UroGen Pharma P/B ratio ttm
No extra charts and metrics for this ticker.